Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1975 1
1976 1
1979 1
1980 2
1981 1
1982 4
1984 1
1985 2
1986 1
1987 2
1991 2
1992 1
1993 1
1994 3
1995 3
1996 1
1997 3
1998 1
1999 4
2001 1
2002 1
2004 2
2005 4
2006 3
2007 1
2008 1
2009 1
2010 2
2011 1
2012 3
2013 1
2014 2
2015 1
2017 4
2018 2
2019 2
2020 9
2021 7
2022 9
2023 6
2024 6
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.
Moline HL, Toepfer AP, Tannis A, Weinberg GA, Staat MA, Halasa NB, Boom JA, Klein EJ, Williams JV, Schuster JE, Goldstein L, McKeever ER, Kalman C, Paden C, Atherton L, Aggarwal M, Roychoudhury P, Piedra PA, Sahni LC, Stewart LS, Selvarangan R, Michaels MG, Schlaudecker EP, Szilagyi PG, Englund JA, Clopper BR, Thornburg NJ, Derado G, McMorrow ML, Dawood FS; New Vaccine Surveillance Network Collaborators. Moline HL, et al. Among authors: paden c. JAMA Pediatr. 2025 Feb 1;179(2):179-187. doi: 10.1001/jamapediatrics.2024.5572. JAMA Pediatr. 2025. PMID: 39652359
Inventory management.
Devine DV, Sher GD, Reesink HW, Panzer S, Hetzel PA, Wong JK, Horvath M, Leitner GC, Schennach H, Nussbaumer W, Genoe K, Cioffi JM, Givisiez FN, Rogerson M, Howe D, Delage G, Sarappa C, Charbonneau, Fu Y, Sarlija D, Vuk T, Strauss Patko M, Balija M, Jukić I, Ali A, Auvinen MK, Jaakonsalo E, Cazenave JP, Waller C, Kientz D, David B, Walther-Wenke G, Heiden M, Lin CK, Tsoi WC, Lee CK, Barotine-Toth K, Sawant RB, Murphy W, Quirke B, Bowler P, Shinar E, Yahalom V, Aprili G, Piccoli P, Gandini G, Tadokaro K, Nadarajan VS, de Kort W, Jansen N, Flanagan P, Forsberg PO, Hervig T, Letowska M, Lachert E, Dudziak K, Antoniewicz-Papis J, de Olim G, Nascimento F, Hindawi S, Teo D, Reddy R, Scholtz J, Swanevelder R, Rovira LP, Sauleda S, Carasa MA, Vaquero MP, Ania MA, Gulliksson H, Holdsworth S, Cotton S, Howell C, Baldwin C, Cusick RM, Geele GA, Paden C, McEvoy P, Gottschall JL, McLaughlin LS, Benjamin RJ, Eder A, Draper NL, AuBuchon JP, León de González G. Devine DV, et al. Among authors: paden c. Vox Sang. 2010 Apr;98(3 Pt 1):e295-363. doi: 10.1111/j.1423-0410.2009.01252.x. Vox Sang. 2010. PMID: 20432515
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025.
Link-Gelles R, Chickery S, Webber A, Ong TC, Rowley EAK, DeSilva MB, Dascomb K, Irving SA, Klein NP, Grannis SJ, Barron MA, Reese SE, McEvoy C, Sheffield T, Naleway AL, Zerbo O, Rogerson C, Self WH, Zhu Y, Lauring AS, Martin ET, Peltan ID, Ginde AA, Mohr NM, Gibbs KW, Hager DN, Prekker ME, Mohamed A, Johnson N, Steingrub JS, Khan A, Felzer JR, Duggal A, Wilson JG, Qadir N, Mallow C, Kwon JH, Columbus C, Vaughn IA, Safdar B, Mosier JM, Harris ES, Chappell JD, Halasa N, Johnson C, Natarajan K, Lewis NM, Ellington S, Reeves EL, DeCuir J, McMorrow M, Paden CR, Payne AB, Dawood FS, Surie D; CDC COVID-19 Vaccine Effectiveness Collaborators. Link-Gelles R, et al. Among authors: paden cr. MMWR Morb Mortal Wkly Rep. 2025 Feb 27;74(6):73-82. doi: 10.15585/mmwr.mm7406a1. MMWR Morb Mortal Wkly Rep. 2025. PMID: 40014628 Free PMC article.
SARS-CoV-2 Delta-Omicron Recombinant Viruses, United States.
Lacek KA, Rambo-Martin BL, Batra D, Zheng XY, Hassell N, Sakaguchi H, Peacock T, Groves N, Keller M, Wilson MM, Sheth M, Davis ML, Borroughs M, Gerhart J, Shepard SS, Cook PW, Lee J, Wentworth DE, Barnes JR, Kondor R, Paden CR. Lacek KA, et al. Among authors: paden cr. Emerg Infect Dis. 2022 Jul;28(7):1442-1445. doi: 10.3201/eid2807.220526. Epub 2022 May 12. Emerg Infect Dis. 2022. PMID: 35551714 Free PMC article.
Benchmark datasets for SARS-CoV-2 surveillance bioinformatics.
Xiaoli L, Hagey JV, Park DJ, Gulvik CA, Young EL, Alikhan NF, Lawsin A, Hassell N, Knipe K, Oakeson KF, Retchless AC, Shakya M, Lo CC, Chain P, Page AJ, Metcalf BJ, Su M, Rowell J, Vidyaprakash E, Paden CR, Huang AD, Roellig D, Patel K, Winglee K, Weigand MR, Katz LS. Xiaoli L, et al. Among authors: paden cr. PeerJ. 2022 Sep 5;10:e13821. doi: 10.7717/peerj.13821. eCollection 2022. PeerJ. 2022. PMID: 36093336 Free PMC article.
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant.
Suthar MS, Manning KE, Ellis ML, Jain S, Bechnak K, Vander Velden J, Laboune F, Henry AR, Godbole S, Kim S, Sahoo MK, Paredes I, Dib SM, Kalash S, Radi C, Hicks H, Tamin A, Gardner M, Bowen N, Cook P, Paden C, Harcourt J, Pinsky BA, Douek DC, Rouphael N, Moreno A. Suthar MS, et al. Among authors: paden c. Lancet Infect Dis. 2025 Mar;25(3):e122-e123. doi: 10.1016/S1473-3099(25)00007-6. Epub 2025 Jan 31. Lancet Infect Dis. 2025. PMID: 39900094 No abstract available.
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron XBB and JN.1 Lineages - United States, May 2023-September 2024.
Ma KC, Castro J, Lambrou AS, Rose EB, Cook PW, Batra D, Cubenas C, Hughes LJ, MacCannell DR, Mandal P, Mittal N, Sheth M, Smith C, Winn A, Hall AJ, Wentworth DE, Silk BJ, Thornburg NJ, Paden CR. Ma KC, et al. Among authors: paden cr. MMWR Morb Mortal Wkly Rep. 2024 Oct 24;73(42):938-945. doi: 10.15585/mmwr.mm7342a1. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39446667 Free PMC article.
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024.
Ma KC, Surie D, Lauring AS, Martin ET, Leis AM, Papalambros L, Gaglani M, Columbus C, Gottlieb RL, Ghamande S, Peltan ID, Brown SM, Ginde AA, Mohr NM, Gibbs KW, Hager DN, Saeed S, Prekker ME, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Khan A, Hough CL, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Kwon JH, Parikh B, Exline MC, Vaughn IA, Ramesh M, Safdar B, Mosier J, Harris ES, Shapiro NI, Felzer J, Zhu Y, Grijalva CG, Halasa N, Chappell JD, Womack KN, Rhoads JP, Baughman A, Swan SA, Johnson CA, Rice TW, Casey JD, Blair PW, Han JH, Ellington S, Lewis NM, Thornburg N, Paden CR, Atherton LJ, Self WH, Dawood FS, DeCuir J. Ma KC, et al. Among authors: paden cr. Clin Infect Dis. 2024 Aug 6:ciae405. doi: 10.1093/cid/ciae405. Online ahead of print. Clin Infect Dis. 2024. PMID: 39107255
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins.
Kumar S, Jain S, Wali B, Zarnitsyna VI, Joshi D, Ellis ML, Lai L, Malik AA, McPherson TO, Godbole S, Patel A, Linderman S, Solis D, Sahoo MK, Bechnak K, Paredes I, Tanios R, Kazzi B, Dib SM, Litvack MB, Wimalasena ST, Hicks H, Tamin A, Bowen NE, Atherton L, Paden C, Harcourt JL, Wentworth DE, Ciric C, West RH, Rostad CA, Teng IT, Wang D, Ortlund EA, Menachery VD, Edupuganti S, Kwong PD, Rouphael N, Pinsky BA, Douek DC, Moreno A, Wrammert J, Suthar MS. Kumar S, et al. Among authors: paden c. Sci Transl Med. 2025 Sep 3;17(814):eadu8067. doi: 10.1126/scitranslmed.adu8067. Epub 2025 Sep 3. Sci Transl Med. 2025. PMID: 40901926
105 results